EarningsQ2 2024 Earnings Report

Vertex Pharmaceuticals (VX1) Q2 2024 Earnings Report

23 Followers

DE:VX1 Q2 2024 EPS Results

Actual EPS-€11.43

Consensus EPS-€10.36

Beat/MissMissed by -€1.07

One Year Ago EPS€3.46

Actual Revenue€2.35B

Expected Revenue€2.37B

Beat/MissMissed by -€25.79M

YoY Revenue Growth+6.02%

QuarterQ2 2024

Date08/01/2024

TimeAfter Close

Conference CallThursday, August 1, 2024

DE:VX1 Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

DE:VX1 Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	4.25 / -	4.275	―
Aug 03, 2026	2026 (Q2)	4.22 / 4.21	4.026	4.65% (+0.19)
May 04, 2026	2026 (Q1)	3.78 / 3.98	3.616	10.10% (+0.37)
Feb 12, 2026	2025 (Q4)	4.55 / 4.48	3.545	26.38% (+0.94)
Nov 03, 2025	2025 (Q3)	4.07 / 4.28	3.901	9.59% (+0.37)
Aug 06, 2025	2025 (Q2)	3.82 / 4.03	-11.428	135.23% (+15.45)
May 05, 2025	2025 (Q1)	3.85 / 3.62	4.24	-14.71% (-0.62)
Feb 10, 2025	2024 (Q4)	3.58 / 3.54	3.741	-5.24% (-0.20)
Nov 04, 2024	2024 (Q3)	3.63 / 3.90	3.634	7.35% (+0.27)
Aug 01, 2024	2024 (Q2)	-10.36 / -11.43	3.465	-429.82% (-14.89)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed